Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2089

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-2089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Image 01)

Chemical structure of diltiazem hydrochloride, showing its molecular configuration including aromatic rings, functional groups, and the hydrochloride component.*

FDA Label Image

Image (Image 02)

Data table presenting adverse reaction rates from placebo-controlled trials comparing diltiazem hydrochloride extended-release capsules (n=607) with placebo (n=301) for treatment of angina and hypertension. It includes percentages for headache, dizziness, bradycardia, first-degree AV block, edema, and asthenia in both groups.*

FDA Label Image

Label (Lbl713352089)

Label for diltiazem hydrochloride extended release 120 mg capsule by Bryant Ranch Prepack. The label states the product is a white capsule, compares to Cardizem CD 120 mg capsule, contains 30 capsules, and includes storage instructions to keep at 20°-25°C (68°-77°F). The NDC number 71335-2089-1 is highlighted, and warnings advise to keep tightly closed and out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.